Sign in
4

Changes in Ownership

Protagenic Therapeutics, Inc.new Filed Acc 0001493152-21-010335

Chief Financial Officer bought 2,000 shares at $2.29 ($4,580)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Arrow Alexander K. Chief Financial Officer 2021-04-29 Purchase +1,000 $2.29 $2,290 119,260 D
Arrow Alexander K. Chief Financial Officer 2021-04-30 Purchase +1,000 $2.29 $2,290 120,260 D
Open-market purchases · 2,000 sh · avg $2.29 · $4,580
Loading xslF345X03/ownership.xml…